Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Here's how they compare: Peptide Primary research area FDA status Advisory committee review BPC-157 Tissue repair, angiogenesis Not approved Yes (free base + acetate) TB-500 Actin regulation, cell migration Not approved Yes MOTS-c Mitochondrial metabolism Not approved Yes KPV Anti-inflammatory Not approved Yes GHK-Cu Copper-peptide skin/healing Not approved Not on 2026 agenda For a deeper comparison of BPC-157 and its most-researched counterpart, see our BPC-157 vs TB-500 research comparison
It is widely studied in cell biology and biochemistry research for its roles in fibroblast dynamics, angiogenesis modulation, and nitric oxide pathway investigation
Preparat w tej formie przenika przez skr i dziaa miejscowo, stymulujc produkcj kolagenu w konkretnych obszarach
This product is not FDA-approved and is strictly intended for research purposes only
Therefore, in terms of the elimination half-life, BPC157 conformed to the characteristics of general peptide drugs
US$ 20.28
US$ 24.60
US$ 24.51
US$ 29.63
US$ 21.29
